Top Sell
| Security | Buy | Sell | Buy (1W) ▼ | Sell (1W) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Trevena Inc. | 3 | 17 | 1 | 1 | €0.30 | €4.60 | 1432.500% |
| Agenus Inc. | 3 | 2 | 0 | 0 | €0.41 | €36.85 | 8804.785% |
| Sangamo Therapeutics Inc. | 12 | 12 | 0 | 0 | €0.42 | €3.63 | 768.022% |
| Aspira Womens Health Inc. | 0 | 1 | 0 | 0 | €1.54 | - | - |
| Savara Inc. | 1 | 1 | 0 | 0 | €3.46 | - | - |
| Pacific Biosciences of California Inc. | 10 | 5 | 0 | 0 | €1.37 | €10.05 | 633.360% |
| Chimerix Inc. | 3 | 1 | 0 | 0 | €0.83 | €5.51 | 564.410% |
| Organovo Holdings Inc. | 0 | 7 | 0 | 0 | €0.76 | - | - |
| Cara Therapeutics Inc. | 11 | 4 | 0 | 3 | €0.26 | €4.61 | 1653.044% |
| Revance Therapeutics Inc. | 0 | 2 | 0 | 0 | €2.48 | - | - |
| Eagle Pharmaceuticals Inc | 0 | 1 | 0 | 0 | €3.82 | - | - |
| Karyopharm Therapeutics Inc. | 9 | 2 | 0 | 0 | €0.87 | €7.38 | 746.945% |
| Akebia Therapeutics Inc. | 7 | 2 | 0 | 0 | €0.87 | €3.64 | 319.862% |
| T2 Biosystems Inc. | 0 | 9 | 0 | 0 | €0.16 | - | - |
| Atara Biotherapeutics Inc. | 2 | 3 | 0 | 0 | €0.37 | €3.00 | 716.549% |
| Coherus Bioscien. | 2 | 2 | 0 | 0 | €1.55 | €3.00 | 93.798% |
| Bellicum Pharmaceuticals Inc. | 0 | 13 | 0 | 0 | €0.064 | - | - |
| Minerva Neurosciences Inc. | 0 | 6 | 0 | 1 | €3.22 | - | - |
| Salarius Pharmaceuticals Inc. | 0 | 1 | 0 | 0 | €0.38 | - | - |
| Rocket Pharmaceuticals Inc | 2 | 1 | 0 | 0 | ? | €32.00 | 52.164% |
| Cytomx Therapeutics Inc | 2 | 1 | 0 | 0 | €1.21 | €50.00 | 4025.413% |
| Anavex Life Sciences Corp | 0 | 2 | 0 | 0 | €3.71 | - | - |
| Orasure Tech | 3 | 1 | 0 | 0 | €3.92 | €8.36 | 113.222% |
| scPharmaceuticals | 4 | 1 | 0 | 0 | €3.60 | €16.45 | 357.050% |